Manuela Casula und University Person-Info 

( Ich bin Manuela Casula)
(1 - 12 von 17
)

Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality ...www.tctmd.com › news › clear-cvd-risk-reduction-p...

www.tctmd.com
· Led by Manuela Casula, PhD (University of Milan, Italy), investigators reported that treatment with alirocumab (Praluent; Regeneron/Sanofi) or ...
+1